OpenAlex
PricingAboutJobs
Log inGet started
Work

Intrinsic resistance to the MEK1/2 inhibitor AZD6244 (ARRY‐142886) is associated with weak ERK1/2 signalling and/or strong PI3K signalling in colorectal cancer cell lines

HTML

Year: 2009
Type: article
Source: International Journal of Cancer
DOI: 10.1002/ijc.24604
Authors: Kathryn Balmanno, Simon D. Chell, Annette S. Gillings, Shaista Hayat, Simon J. Cook
Institution: Babraham Institute
Language: English

Topic: Melanoma and MAPK Pathways
Subfield: Molecular Biology
Field: Biochemistry, Genetics and Molecular Biology
Domain: Life Sciences
Keywords: selumetinib, MEK inhibitors, intrinsic drug resistance, colorectal cancer cell lines, ERK signaling, PI3K signaling, Akt, KRAS mutation, BRAF mutation, MAPK signaling, PI3K/mTOR inhibitors, combination therapy, cell proliferation, apoptosis, G1 cell cycle arrest
SDG: Good health and well-being

Open Access status: closed

Funders: AstraZeneca, Biotechnology and Biological Sciences Research Council
Awards: G2012023987, G7215072125
OpenAlex ID: W1963713713
FWCI: 3.325
Cites: 56
Cited by: 152
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms
Security